Tamara Bonilla-Castano

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry.

Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry.

Journal: Cancer

Published: November 03, 2025

Mesenchymal stem cells-like as a prognostic biomarker in patients diagnosed with acute myeloid leukemia.

Mesenchymal stem cells-like as a prognostic biomarker in patients diagnosed with acute myeloid leukemia.

Journal: Scientific reports

Published: July 03, 2025

V217F MYD88 mutation in low-grade B-cell lymphomas with plasmacytic differentiation: a diagnostic challenge.

V217F MYD88 mutation in low-grade B-cell lymphomas with plasmacytic differentiation: a diagnostic challenge.

Journal: Pathology

Published: November 17, 2024

Therapeutics of acute myeloid leukemia with central nervous system involvement.

Therapeutics of acute myeloid leukemia with central nervous system involvement.

Journal: Clinical hematology international

Published: November 04, 2024

Spontaneous Remission of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report.

Spontaneous Remission of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report.

Journal: Medicina (Kaunas, Lithuania)

Published: February 28, 2024

Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage.

Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage.

Journal: Annals of hematology

Published: August 27, 2023

Spontaneous Remission of Acute Myeloid Leukemia: A Case Report.

Spontaneous Remission of Acute Myeloid Leukemia: A Case Report.

Journal: Medicina (Kaunas, Lithuania)

Published: June 09, 2022

No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.

No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.

Journal: Disease markers

Published: May 05, 2022

Flow Cytometry and Molecular Techniques Could Complement Morphological Detection of Leukemic Infiltration in Ascitic Fluids: A Case Report.

Flow Cytometry and Molecular Techniques Could Complement Morphological Detection of Leukemic Infiltration in Ascitic Fluids: A Case Report.

Journal: Medicina (Kaunas, Lithuania)

Published: January 04, 2022

Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens.

Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens.

Journal: Scientific reports

Published: June 07, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026